DK0788792T3 - Plasterfremstilling af matrixtype - Google Patents

Plasterfremstilling af matrixtype

Info

Publication number
DK0788792T3
DK0788792T3 DK95920235T DK95920235T DK0788792T3 DK 0788792 T3 DK0788792 T3 DK 0788792T3 DK 95920235 T DK95920235 T DK 95920235T DK 95920235 T DK95920235 T DK 95920235T DK 0788792 T3 DK0788792 T3 DK 0788792T3
Authority
DK
Denmark
Prior art keywords
matrix type
active substance
acid
physiological active
organic acid
Prior art date
Application number
DK95920235T
Other languages
Danish (da)
English (en)
Inventor
Naruhito Higo
Ken-Ichi Komori
Takaaki Terahara
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of DK0788792T3 publication Critical patent/DK0788792T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacture Of Alloys Or Alloy Compounds (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DK95920235T 1994-11-29 1995-06-01 Plasterfremstilling af matrixtype DK0788792T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31911794A JP3908795B2 (ja) 1994-11-29 1994-11-29 ケトチフェン含有経皮投与製剤
PCT/JP1995/001073 WO1996016642A1 (fr) 1994-11-29 1995-06-01 Composition de timbre transdermique du type matriciel

Publications (1)

Publication Number Publication Date
DK0788792T3 true DK0788792T3 (da) 2003-01-13

Family

ID=18106658

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95920235T DK0788792T3 (da) 1994-11-29 1995-06-01 Plasterfremstilling af matrixtype

Country Status (14)

Country Link
US (1) US5866157A (de)
EP (1) EP0788792B1 (de)
JP (1) JP3908795B2 (de)
KR (1) KR100385268B1 (de)
CN (1) CN1065428C (de)
AT (1) ATE229798T1 (de)
AU (1) AU708123B2 (de)
CA (1) CA2206303A1 (de)
DE (1) DE69529228T2 (de)
DK (1) DK0788792T3 (de)
ES (1) ES2184801T3 (de)
HK (1) HK1001853A1 (de)
PT (1) PT788792E (de)
WO (1) WO1996016642A1 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW411277B (en) * 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
DE69829961T2 (de) * 1997-02-28 2006-02-23 Minnesota Mining And Mfg. Co., Saint Paul Transdermale vorrichtung zur verabreichungvon von testosteron
JP2001515091A (ja) * 1997-08-29 2001-09-18 アベリー・デニソン・コーポレイション 生物学的流体を吸収する感圧接着剤
US6180133B1 (en) * 1997-11-25 2001-01-30 Watson Pharmaceuticals, Inc. Antioxidant composition for topical/transdermal prevention and treatment of wrinkles
JP4205778B2 (ja) * 1998-04-17 2009-01-07 久光製薬株式会社 貼付製剤
WO2000001384A1 (fr) * 1998-07-01 2000-01-13 Lead Chemical Co., Ltd. Preparation a base de ketotifene destinee a etre absorbee par voie percutanee
JP3943724B2 (ja) * 1998-07-31 2007-07-11 東光薬品工業株式会社 フェンタニル含有経皮投与マトリックス型貼付剤
CA2318047A1 (en) * 1998-10-05 2000-04-13 Yutoku Pharmaceutical Ind. Co., Ltd. Tape material for transcutaneous absorption
US6475514B1 (en) * 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
DE60045153D1 (de) * 1999-04-13 2010-12-09 Hisamitsu Pharmaceutical Co Zubereitungen zur perkutanen absorption
US6417227B1 (en) 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
ES2356704T3 (es) 1999-07-15 2011-04-12 Hisamitsu Pharmaceutical Co. Inc. Preparaciones percutaneamente absobibles.
PT1201232E (pt) * 1999-07-27 2007-07-24 Hisamitsu Pharmaceutical Co Emplastros papa uso externo.
US20040142024A1 (en) * 1999-07-27 2004-07-22 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use
CA2387370C (en) * 1999-10-15 2008-12-23 Pola Chemical Industries Inc. Percutaneous sorbefacients for electroporation
WO2001068061A1 (fr) * 2000-03-17 2001-09-20 Hisamitsu Pharmaceutical Co., Inc. Preparation adhesive protegeant des uv
KR100600456B1 (ko) * 2000-04-18 2006-07-13 히사미쓰 세이야꾸 가부시키가이샤 항염증제 함유 첩부제
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
WO2002038139A1 (fr) * 2000-11-07 2002-05-16 Hisamitsu Pharmaceutical Co., Inc. Preparation pharmaceutique du type a absorption percutanee
DE10056011A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Hautfreundliches Wirkstoffpflaster zur insbesondere transdermalen Verabreichung ätherischer Öle
DE10056010A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Pflaster mit hautpflegenden Substanzen
US7988991B2 (en) * 2001-03-07 2011-08-02 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
DE10121471A1 (de) * 2001-05-02 2002-11-07 Beiersdorf Ag Oberflächendotierte wirkstoffhaltige Pflaster
WO2002092069A1 (en) * 2001-05-11 2002-11-21 Elan Corporation, Plc Permeation enhancers
CN1541112A (zh) * 2001-08-10 2004-10-27 �ù���ҩ��ʽ���� 经皮吸收制剂
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
WO2003092591A2 (en) * 2002-04-30 2003-11-13 Npd Llc Multi-phasic delivery via transmucosal absorption of antiemetic medicaments
US20050163831A1 (en) * 2002-08-02 2005-07-28 Hisamitsu Pharmaceutical Co., Inc. Patch for transdermal administration
JP4792193B2 (ja) * 2002-08-28 2011-10-12 久光製薬株式会社 貼付剤
JP4354678B2 (ja) * 2002-08-28 2009-10-28 久光製薬株式会社 貼付剤
US7785622B2 (en) * 2002-09-13 2010-08-31 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch for fentanyl administration
JP4543274B2 (ja) * 2002-10-01 2010-09-15 大正製薬株式会社 点鼻剤組成物
TWI296531B (en) * 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
PL219030B1 (pl) 2003-02-21 2015-03-31 Schering Ag Transdermalny system terapeutyczny w postaci plastra odporny na działanie promieniowania UV
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
EP1641441B1 (de) * 2003-04-30 2014-03-12 Purdue Pharma L.P. Manipulationssichere transdermale dosierform enthaltend eine wirkstoffkomponente und eine gegenkomponente an der distalen stelle der wirkstoffschicht
KR101184810B1 (ko) 2003-06-20 2012-09-20 데이고꾸세이약꾸가부시끼가이샤 툴로부테롤 함유 패치
JP4694967B2 (ja) * 2003-07-31 2011-06-08 久光製薬株式会社 貼付剤
JP4468669B2 (ja) * 2003-09-22 2010-05-26 久光製薬株式会社 低刺激性貼付剤
WO2005046600A2 (en) * 2003-11-07 2005-05-26 Nexmed Holdings, Inc. Transdermal tulobuterol delivery
US20050112183A1 (en) * 2003-11-25 2005-05-26 Galer Bradley S. Compositions and methods for treating neuropathic sensory loss
US8668925B2 (en) * 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
JP4881006B2 (ja) * 2004-01-20 2012-02-22 ニプロパッチ株式会社 ツロブテロール貼付剤
JP4989892B2 (ja) * 2004-01-30 2012-08-01 久光製薬株式会社 貼付剤入り包装袋
WO2005115355A1 (ja) * 2004-05-28 2005-12-08 Hisamitsu Pharmaceutical Co., Inc. 貼付製剤
US20070232629A1 (en) * 2004-06-01 2007-10-04 Toshiro Yamaguchi Adhesive Patch
JP4824963B2 (ja) * 2004-08-12 2011-11-30 日東電工株式会社 貼付材及び貼付製剤
JP4745747B2 (ja) * 2004-08-12 2011-08-10 日東電工株式会社 フェンタニル含有貼付製剤
US7744918B2 (en) * 2004-11-22 2010-06-29 Hisamitsu Pharmaceutical Co., Inc. Drug-containing patch
JP5075334B2 (ja) * 2004-11-22 2012-11-21 久光製薬株式会社 薬物含有貼付剤
EP1857103B1 (de) * 2005-02-28 2018-10-24 Hisamitsu Pharmaceutical Co., Inc. Transdermal absorbierbare präparation
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
PT2117521E (pt) 2006-11-03 2012-09-10 Durect Corp Sistemas de administração transdérmica que compreendem bupivacaína
US20080152592A1 (en) * 2006-12-21 2008-06-26 Bayer Healthcare Llc Method of therapeutic drug monitoring
US20100047327A1 (en) * 2007-01-31 2010-02-25 Tetsuji Kuwahara Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same
US20100210932A1 (en) * 2007-03-20 2010-08-19 Bayer Healthcare Llc Method of analyzing an analyte
JP5242950B2 (ja) * 2007-06-15 2013-07-24 日東電工株式会社 ゲル組成物およびその用途
JP6054013B2 (ja) * 2008-02-27 2016-12-27 久光製薬株式会社 貼付製剤
US9155725B2 (en) * 2008-02-27 2015-10-13 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
JP2012158572A (ja) * 2011-02-02 2012-08-23 Nitto Denko Corp 貼付製剤の製造方法
EP2907515B1 (de) * 2012-10-11 2019-01-02 Hisamitsu Pharmaceutical Co., Inc. Hautpflaster
US8697043B1 (en) 2013-01-08 2014-04-15 Chattem, Inc. Odor suppression of volatile organic analgesic compounds and method of use
US20140234394A1 (en) * 2013-02-19 2014-08-21 William A. McDonough Benefical contact surfaces for functional objects
JP6151935B2 (ja) * 2013-03-11 2017-06-21 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
EP3045166B1 (de) 2013-09-11 2020-12-16 MEDRx Co., Ltd. Neuartige basiszusammensetzung für ein bandmittel
CN109966241A (zh) * 2019-04-16 2019-07-05 浙江大学 一种促渗组合物在外用制剂经皮促渗中的应用
CN110507638A (zh) * 2019-10-14 2019-11-29 姜涛 一种膏药、贴剂专用基质

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2915887A1 (de) * 1979-04-19 1980-11-06 Wacker Chemie Gmbh Copolymerisate auf der basis von acrylestern, vinylacetat und aethylen
JPS56140916A (en) * 1980-04-04 1981-11-04 Sekisui Chem Co Ltd Adhesive tape or sheet for medical treatment
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
JPS62181226A (ja) * 1986-02-05 1987-08-08 Ikeda Mohandou:Kk 消炎鎮痛外用剤
JP2572763B2 (ja) * 1987-04-02 1997-01-16 帝國製薬株式会社 エトフェナマ−ト含有貼付薬
JPH01290630A (ja) * 1988-05-17 1989-11-22 Takeda Chem Ind Ltd 経皮用製剤
JP2788754B2 (ja) * 1989-05-12 1998-08-20 日東電工株式会社 シート状経皮吸収デバイス
DE69010076T2 (de) * 1989-05-25 1994-12-08 Takeda Chemical Industries Ltd Transdermales therapeutisches Mittel.
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
US5225199A (en) * 1990-04-24 1993-07-06 Teijin Limited Pharmaceutical plasters
DE69228313T2 (de) * 1991-08-30 1999-09-23 Hisamitsu Pharmaceutical Co Entzündungshemmendes, analgetisches pflaster
JPH06100439A (ja) * 1992-09-18 1994-04-12 Sekisui Chem Co Ltd 経皮吸収貼付剤
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration

Also Published As

Publication number Publication date
KR100385268B1 (ko) 2003-08-19
US5866157A (en) 1999-02-02
PT788792E (pt) 2003-03-31
DE69529228T2 (de) 2003-07-17
WO1996016642A1 (fr) 1996-06-06
AU2575695A (en) 1996-06-19
JPH08157365A (ja) 1996-06-18
DE69529228D1 (de) 2003-01-30
AU708123B2 (en) 1999-07-29
ATE229798T1 (de) 2003-01-15
CN1065428C (zh) 2001-05-09
EP0788792A4 (de) 1998-05-27
EP0788792A1 (de) 1997-08-13
EP0788792B1 (de) 2002-12-18
ES2184801T3 (es) 2003-04-16
JP3908795B2 (ja) 2007-04-25
CA2206303A1 (en) 1996-06-06
CN1171736A (zh) 1998-01-28
HK1001853A1 (en) 1998-07-17

Similar Documents

Publication Publication Date Title
DK0788792T3 (da) Plasterfremstilling af matrixtype
ATE485815T1 (de) Zubereitungen zur perkutanen absorption
CA2217888A1 (en) Triacetin as a transdermal penetration enhancer
EP0251464A3 (de) Zusammensetzung zur Insektenbekämpfung
NO173365C (no) Fremgangsm}te for fremstilling av et i det vesentlige ikke-sviende, vandig, antiinflammatorisk steroidpreparat egnet for intranasal administerering
DE3872382D1 (de) Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.
DK0695177T3 (da) Plaster indeholdende aktivt stof
DK0582239T3 (da) Farmaceutisk og/eller kosmetisk formulering
DE69715049D1 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
MC2094A1 (fr) Medicament contenant de l'acide dihydrolipoique en tant que substance active,procede de preparation
DE69414904D1 (de) Silikat-Polymer enthaltende pharmazeutische Zusammensetzungen
ATE493121T1 (de) Perkutane resorbierbare zubereitungen
ES2023880B3 (es) Agentes fijadores para el cabello.
DE3864149D1 (de) Salbengrundlage und salbe.
DK199789D0 (da) Anvendelse af et phenylquinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et topisk farmaceutisk praeparat til behandling af hud- og/eller slimepithelsygdomme
SE9202066D0 (sv) Prokaterol-haltigt preparat foer paafoering paa huden
DE69706070D1 (de) Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazol
FI910112A (fi) Preparat foer lokalt bruk.
ES2045369T3 (es) Sistema terapeutico transdermico con norseudoefedrina como componente activo.
DK0468351T3 (da) Ortopædisk terapisko og indersko
KR930016101A (ko) 아데노신 3',5'-사이클릭 포스페이트 유도체를 함유하는 연고
ES2129739T3 (es) Poliuretanos estabilizados, termoplasticos.